For e.g. let's say that you (the client - a leading #pharmaceuticals major) have a strong oncology drug in your portfolio that has a lot of strengths going for it like:
3. Powerful performance that is validated by an independent subgroup analysis of the most volatile patient population (of the already high-risk trial population)
But for some reason, you don't seem to generate many #prescriptions when put into market - where your #competitor's product (let's call it P) is a class-leader with nearly 60% market share as an L1 maintenance therapy in key #Oncology indications!
You are worried about this....and know that the competitor company is preparing to strengthen its (near-absolute) leadership based on trial results where P is combined with another class-leading checkpoint inhibitor. So, effectively, your window of opportunity is narrow and closing fast!
So, when you come to GRG Health, you get to work with a team that knows:
1. 'exactly' which providers to speak with
2. 'exactly' what to ask about
3. 'exactly' where to probe in-depth and
4. 'exactly' what to deliver
Further, when the #insights emerge, you find out 'exactly' why P is beating you (because of its relatively higher time on market and better awareness levels (vs. your product)).
And in just three weeks 'exactly', through just a few well-targeted interviews (N = 45, US) with 'hard-to-reach' #providers, you have been shown 'exactly' what to focus on.....and how 'exactly' to tweak your #strategy for better #prescription turnout!
GRG Health felt that was rather helpful.....and that's what the client just told us, 'exactly'!
So, when you think oncology primary research (esp. #Ovary, #Breast, #Lung and #Colorectal), please feel free to reach out.....and if you are asking if you should visit the GRG Health website or drop an email for a quick discussion about your Research needs....the team at GRG Health would respond, "exactly!"🙂